Determined to be 85% of institutional reserves
Less distribution available after listing
215,500 won at the upper limit the next day
SK Bioscience, which succeeded in collecting about 64 trillion won in margin from general subscriptions, will be listed on the stock market on the 18th. SK Biopharm entered last year(111,500 +1.36%), Kakao Games(51,600 +1.38%)Likewise, it is noteworthy whether the initial price on the first day of listing will be doubled than the public offering price, and then the upper limit (aka tasang) can be continued.
According to the Korea Exchange on the 17th, SK Bioscience will start trading in the securities market with the opening of the stock market on the 18th. Asking prices are accepted from 8:30 am to 9:00 am, and the initial price is set in the range of 90 to 200% of the public offering price. The initial price is set at 130,000 won, which is twice the public offering price (65,000 won), and if you go directly to the upper limit, the stock price on the first day can rise to a maximum of 169,000 won. The market capitalization will increase from 4,900 trillion won to 12.900 trillion won based on the public offering price. Immediately after listing, it quickly entered the 29th place in the market capitalization of the securities market. If the upper limit is recorded again on the second day of listing, the stock price will soar to 215,500 won and the market cap to 16.800 billion won. SK Biopharmaceuticals and Kakao Games, which recorded a’tasang’ after entering the stock market last year, closed at the upper limit for 3 consecutive trading days and 2 consecutive trading days from the date of listing, respectively.
Stock prices are likely to maintain the upper limit for more than two days as they set a record-high box office record in institutional demand forecasting and general subscription. Like SK Biopharm and Kakao Games, if the stock becomes’out of stock’ due to the rush of buying from the day of listing, the upper limit can be maintained while the volume is locked.
It is also a good thing that the amount of available distribution on the day of listing is small. SK Bioscience has committed to holding a mandatory reserve in 10.76 million shares, which is 85.26% of the institution’s volume. Commitment-holding stocks cannot be sold for 15 to 6 months. The number of shares available for circulation on the date of listing was 8.87 million, 7510 shares, accounting for only 11.63% of the issued shares. SK Biopharm (13.1%), Kakao Games (20.5%), Big Hit(231,000 +5.48%)Less than (19.8%). The size of distribution stocks based on the public offering price is 5784 billion won, which is two-thirds of Big Hit (904.5 billion won).
The market situation is also okay. Neo-Imuntech, a recently listed biotechnology company, has a stock price exceeding twice that of the public offering price on the first day of listing, and the stock price of Biodyne, which had a low competition rate for general subscriptions, is exceeding the offering price. An industry insider said, “As the number of accounts on the same level of public offering stocks was gathered, individuals will be in a fierce struggle to determine the timing of the sale.
Reporter Jeon Ye-jin [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution